2-Oxobutanoic Acid

Identification

Generic Name
2-Oxobutanoic Acid
DrugBank Accession Number
DB04553
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 102.0886
Monoisotopic: 102.031694058
Chemical Formula
C4H6O3
Synonyms
Not Available
External IDs
  • FEMA NO. 3723
  • NSC-60533

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
U1-aminocyclopropane-1-carboxylate deaminaseNot AvailablePseudomonas sp. (strain ACP)
UMethylmalonyl-CoA carboxyltransferase 5S subunitNot AvailablePropionibacterium freudenreichii subsp. shermanii
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
PathwayCategory
Glycine and Serine MetabolismMetabolic
Propanoate MetabolismMetabolic
Selenoamino Acid MetabolismMetabolic
Cystathionine beta-Synthase DeficiencyDisease
Methionine MetabolismMetabolic
Malonic AciduriaDisease
Methionine Adenosyltransferase DeficiencyDisease
Non-Ketotic HyperglycinemiaDisease
SarcosinemiaDisease
Homocystinuria, Cystathionine beta-Synthase DeficiencyDisease
Dihydropyrimidine Dehydrogenase Deficiency (DHPD)Disease
Methylmalonic Aciduria Due to Cobalamin-Related DisordersDisease
S-Adenosylhomocysteine (SAH) Hydrolase DeficiencyDisease
Glycine N-Methyltransferase DeficiencyDisease
Dimethylglycine Dehydrogenase DeficiencyDisease
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)Disease
HypermethioninemiaDisease
Threonine and 2-Oxobutanoate DegradationMetabolic
Homocysteine DegradationMetabolic
Dimethylglycine Dehydrogenase DeficiencyDisease
Hyperglycinemia, Non-KetoticDisease
Malonyl-CoA Decarboxylase DeficiencyDisease
gamma-Cystathionase Deficiency (CTH)Disease
Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation TypeDisease
3-Phosphoglycerate Dehydrogenase DeficiencyDisease
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Keto acids and derivatives
Sub Class
Short-chain keto acids and derivatives
Direct Parent
Short-chain keto acids and derivatives
Alternative Parents
Alpha-keto acids and derivatives / Alpha-hydroxy ketones / Monocarboxylic acids and derivatives / Carboxylic acids / Organic oxides / Hydrocarbon derivatives
Substituents
Aliphatic acyclic compound / Alpha-hydroxy ketone / Alpha-keto acid / Carbonyl group / Carboxylic acid / Carboxylic acid derivative / Hydrocarbon derivative / Ketone / Monocarboxylic acid or derivatives / Organic oxide
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
2-oxo monocarboxylic acid, short-chain fatty acid (CHEBI:30831) / Oxo fatty acids (C00109) / Oxo fatty acids (LMFA01060002)
Affected organisms
Not Available

Chemical Identifiers

UNII
B92RB6HY1A
CAS number
600-18-0
InChI Key
TYEYBOSBBBHJIV-UHFFFAOYSA-N
InChI
InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)
IUPAC Name
2-oxobutanoic acid
SMILES
CCC(=O)C(O)=O

References

General References
Not Available
Human Metabolome Database
HMDB0000005
KEGG Compound
C00109
PubChem Compound
58
PubChem Substance
46504977
ChemSpider
57
ChEBI
30831
ChEMBL
CHEMBL171246
ZINC
ZINC000001532540
PDBe Ligand
2KT
PDB Entries
1rr2 / 1tzk / 2kto / 2q1a / 2q1c / 2uyn / 3tdf / 4b5t / 4woq / 8biu
show 3 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)33 °CPhysProp
Predicted Properties
PropertyValueSource
Water Solubility79.2 mg/mLALOGPS
logP0.07ALOGPS
logP0.77Chemaxon
logS-0.11ALOGPS
pKa (Strongest Acidic)3.19Chemaxon
pKa (Strongest Basic)-9.7Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area54.37 Å2Chemaxon
Rotatable Bond Count2Chemaxon
Refractivity22.62 m3·mol-1Chemaxon
Polarizability9.2 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9869
Blood Brain Barrier+0.9228
Caco-2 permeable-0.6181
P-glycoprotein substrateNon-substrate0.776
P-glycoprotein inhibitor INon-inhibitor0.8942
P-glycoprotein inhibitor IINon-inhibitor0.9606
Renal organic cation transporterNon-inhibitor0.9541
CYP450 2C9 substrateNon-substrate0.8362
CYP450 2D6 substrateNon-substrate0.9289
CYP450 3A4 substrateNon-substrate0.7712
CYP450 1A2 substrateNon-inhibitor0.9532
CYP450 2C9 inhibitorNon-inhibitor0.9075
CYP450 2D6 inhibitorNon-inhibitor0.9664
CYP450 2C19 inhibitorNon-inhibitor0.9475
CYP450 3A4 inhibitorNon-inhibitor0.9805
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9876
Ames testNon AMES toxic0.8311
CarcinogenicityNon-carcinogens0.5313
BiodegradationReady biodegradable0.9387
Rat acute toxicity1.6927 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9835
hERG inhibition (predictor II)Non-inhibitor0.969
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-0gbj-1900000000-8daa299f5bc38a7f9b3e
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-014s-1910000000-d01bcd7b41fdcc634eea
GC-MS Spectrum - GC-MS (1 MEOX; 1 TMS)GC-MSsplash10-000i-9200000000-3b3816ffee5771215904
GC-MS Spectrum - GC-MS (1 MEOX; 1 TMS)GC-MSsplash10-000i-6910000000-5b264d5f7e53f3e80b12
GC-MS Spectrum - GC-MS (2 TMS)GC-MSsplash10-001i-6950000000-db7f6a0f03a8cce59bae
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0a6r-9000000000-32269ef3ef778c482f99
GC-MS Spectrum - EI-BGC-MSsplash10-0ftb-0920000000-a6c93d8761ef15f7f7d4
GC-MS Spectrum - EI-BGC-MSsplash10-014i-0920000000-406fe70e72dbd9c3f274
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0gbj-1900000000-8daa299f5bc38a7f9b3e
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-014s-1910000000-d01bcd7b41fdcc634eea
GC-MS Spectrum - GC-MSGC-MSsplash10-000i-9200000000-3b3816ffee5771215904
GC-MS Spectrum - GC-MSGC-MSsplash10-000i-6910000000-5b264d5f7e53f3e80b12
GC-MS Spectrum - GC-MSGC-MSsplash10-001i-6950000000-db7f6a0f03a8cce59bae
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-000i-8900000000-97bab6630de4df095a7f
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-000i-9200000000-0ebb2354fe3f935fe177
MS/MS Spectrum - Quattro_QQQ 10V, NegativeLC-MS/MSsplash10-0pb9-9600000000-53ebb7164f74d7d92a4d
MS/MS Spectrum - Quattro_QQQ 25V, NegativeLC-MS/MSsplash10-0zfr-5900000000-1db864754705beb79b55
MS/MS Spectrum - Quattro_QQQ 40V, NegativeLC-MS/MSsplash10-0udi-9800000000-5ba5b9ede5b1bc389b87
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , NegativeLC-MS/MSsplash10-0udi-0900000000-bfdcad5bc3ed586bdede
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0udi-0900000000-bfdcad5bc3ed586bdede
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-9000000000-f9cf01f57aa08ed9654e
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-9400000000-cb98ca31c9847f28f5d2
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-9000000000-01b16b4ae4545442ab05
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-052r-9000000000-f8effab59678ab0a3aea
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-c112e30008b61302bd77
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-000i-9000000000-6c4d67e304350b726035
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-115.3433629
predicted
DarkChem Lite v0.1.0
[M-H]-115.3086629
predicted
DarkChem Lite v0.1.0
[M-H]-115.4037629
predicted
DarkChem Lite v0.1.0
[M-H]-123.94716
predicted
DeepCCS 1.0 (2019)
[M+H]+116.4409629
predicted
DarkChem Lite v0.1.0
[M+H]+115.4126629
predicted
DarkChem Lite v0.1.0
[M+H]+115.7842629
predicted
DarkChem Lite v0.1.0
[M+H]+126.74562
predicted
DeepCCS 1.0 (2019)
[M+Na]+115.4075629
predicted
DarkChem Lite v0.1.0
[M+Na]+115.1618629
predicted
DarkChem Lite v0.1.0
[M+Na]+134.93004
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Pseudomonas sp. (strain ACP)
Pharmacological action
Unknown
General Function
Pyridoxal phosphate binding
Specific Function
Catalyzes a cyclopropane ring-opening reaction, the irreversible conversion of 1-aminocyclopropane-1-carboxylate (ACC) to ammonia and alpha-ketobutyrate. Allows growth on ACC as a nitrogen source.
Gene Name
acdS
Uniprot ID
Q00740
Uniprot Name
1-aminocyclopropane-1-carboxylate deaminase
Molecular Weight
36671.515 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
Kind
Protein
Organism
Propionibacterium freudenreichii subsp. shermanii
Pharmacological action
Unknown
General Function
Methylmalonyl-coa carboxytransferase activity
Specific Function
The 5S subunit specifically catalyzes the transfer of the carboxyl group from biotin of the 1.3S subunit to pyruvate to form oxaloacetate and 1.3S biotin.
Gene Name
Not Available
Uniprot ID
Q70AC7
Uniprot Name
Methylmalonyl-CoA carboxyltransferase 5S subunit
Molecular Weight
55649.06 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52